Patent · US Active

5-(3,4-dichloro-phenyl)-N-(2-hydroxy-cyclohexyl)-6-(2,2,2-trifluoro-ethoxy)-nicotinamide and salts thereof

US8227491B2 · kind B2 · utility

2Cited by

1References

4Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Stephan Roever · Inzlingen, DE
Matthew Wright · Basel, CH

Key dates

Filing date	Sep 3, 2010
Grant date	Jul 24, 2012
Priority date	—
Expiry date	Feb 11, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P39/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a compound of formula I,in all its isomeric forms and pharmaceutically acceptable salts thereof, their manufacture, pharmaceutical compositions containing them and their use as medicaments for the treatment and/or prophylaxis of diseases which can be treated with HDL-cholesterol raising agents, such as dyslipidemia, atherosclerosis and cardiovascular diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.